Articles tagged with Clinical Trials
A large clinical trial found no significant difference in mortality between fresh and older blood in critically ill patients. The Age of Blood Evaluation (ABLE) study, conducted across 64 centers, showed that 423 patients died within 90 days with fresh blood compared to 398 with older blood.
The BRIGHT trial demonstrated the superiority of bivalirudin over heparin monotherapy and heparin plus tirofiban in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Bivalirudin reduced bleeding rates while maintaining comparable rates of major adverse cardiac events.
A study found that noninferiority trials often lack clear justification for chosen margins, leading to concerns about their validity. The authors highlight the need for improved registration and reporting standards within publicly accessible trial registries.
A review of clinical trial data found no effect on systolic and diastolic blood pressure due to vitamin D supplementation. The analysis included 46 trials with over 4,500 participants, concluding that vitamin D or its analogues should not be used as an individual patient treatment for hypertension.
A large study has found that routine blood clot removal during heart attack treatment does not benefit patients and may increase the risk of stroke. The TOTAL trial involved over 10,700 patients and showed no differences in cardiovascular outcomes between those who received clot removal and those who did not.
Self-expanding TAVR shows continued survival advantage over standard surgery in high-risk patients with severe aortic stenosis. At two years, TAVR had 4.8% more survivors than surgery, and lower rates of strokes and major cardiovascular events.
A study published in JAMA Network found that combining folic acid with the hypertension medication enalapril significantly reduced the risk of first stroke among over 20,000 Chinese adults with high blood pressure. The treatment also showed significant reductions in ischemic stroke and composite cardiovascular events.
A new device called TriGuard has been tested in a multicenter trial to protect the brain during heart-valve replacement procedures. The results show that patients with protection had fewer ischemic brain lesions and improvements in cognitive function, including short-term memory and delayed memory.
A new brain shield device has shown improved in-hospital safety outcomes, including lower rates of major adverse cardiovascular and cerebrovascular events. The device also demonstrated benefits for patients' cognitive scores at discharge, with better performance on neurocognitive tests.
The SAPIEN 3 heart valve demonstrated lower death, stroke, and paravalvular leak rates than earlier generation devices in high-risk patients. In intermediate-risk patients, the device showed encouraging results, with a reduced rate of major vascular complications and fewer instances of heart attacks and annular rupture.
The SAPIEN transcatheter heart valve is a feasible option for high-risk patients with severe aortic stenosis, but valve leakage remains a significant issue. At five years, death and stroke rates were equivalent to open-heart surgery, but rehospitalization rates and functional outcomes differed.
The HEART Pathway, a new protocol, helps emergency departments evaluate patients with acute chest pain more efficiently. It has been shown to reduce cardiac tests, early discharges, and hospital stays while maintaining patient safety.
Patients undergoing non-emergency cardiac surgery were given either a low or high haemoglobin threshold for transfusion, with the researchers finding that more patients died in the 'low' group. Health care costs and serious complications were similar in both groups, challenging prevailing guidelines.
Duke Medicine researchers found that only 13.4% of clinical trials reported findings within the required one-year window, with industry-sponsored trials reporting at 17%, while academic/non-NIH-funded trials reported at just 5.7%. The lack of transparency hampers progress and violates obligations to patients.
A new natural treatment for Alzheimer's disease, withanamides, is being developed by Michigan State University. The compound has shown to protect brain cells from damage caused by the rogue protein BAP, which is a common factor in Alzheimer's progression.
Researchers found that patients who received blood transfusions at a higher haemoglobin level had fewer serious complications and deaths after cardiac surgery. The study challenges current guidelines and health policy, suggesting that a more liberal approach to transfusion may be safer and more cost-effective
Researchers at UTHealth successfully enrolled patients from other hospitals into an acute stroke clinical trial using telemedicine. This breakthrough enables the study of stroke treatment on a larger scale, as it was previously limited to large centers with expertise in treating strokes quickly.
A study of 12,000 TAVR patients found a one-year mortality rate of nearly 24% and rehospitalization rates at 47%. The results provide insight into the outcomes of this less invasive procedure for severe aortic stenosis patients.
Research shows that training can effectively eliminate the age deficit in contrast sensitivity, improving visual function in older adults. The study found improvements in both near and far acuity, allowing participants to read more letters on eye charts after training.
A new study by University of Vermont neurologist Andrew Solomon and colleagues reports that MS patients want to know the details of their physicians' financial relationships with pharmaceutical companies. The study found that disclosure of these relationships can influence patients' decisions to participate in clinical trials.
A new cancer drug called PAC-1, which targets cancer cells by restoring an enzyme's activity, is now entering phase I clinical trials in humans. The drug was first tested in pet dogs with spontaneously occurring cancers and showed promising results.
The University of Pittsburgh is leading a $14 million clinical trial comparing two approaches to treat acute lower back pain, one with usual care and the other with cognitive behavioral therapy. The study aims to reduce chronic lower back pain and its effects on daily life.
The European Organisation for Research and Treatment of Cancer recently published an article discussing the management of locally advanced inoperable breast cancer. The review, led by Dr. Konstantinos Tryfonidis, examines current treatment options and future directions for improving outcomes.
A clinical trial at UTHealth investigates the use of a physician-monitored app to encourage minority stroke patients to lose weight and manage risk factors. The study aims to close the racial disparities gap in stroke care, with patients randomized to usual care or the app group.
A new study found that consuming peanut-containing snacks from infancy can prevent peanut allergy in high-risk infants. In contrast, avoiding peanuts led to a higher risk of developing the allergy by age 5. The findings suggest a shift in advice for parents and healthcare providers to promote early consumption of allergenic foods.
Patients receiving fondaparinux had a lower risk of major bleeding events and death following a heart attack compared to those receiving low-molecular-weight heparin. This association was observed in both hospital settings and six months post-incident.
A clinical trial led by the University of Southern California has successfully implanted an ABI device in four children who were previously unable to hear. The device stimulates neurons directly at the human brainstem, bypassing the inner ear entirely and showing promising results in young children.
The HPV vaccine was highly effective against common cancer-causing human papillomaviruses beyond types 16 and 18. Young women vaccinated before sexual debut showed substantial protection against cervical abnormalities and precancerous cell transformations.
A six-year clinical trial found that patients with low blood flow to the back of the brain are at a higher risk of recurrent stroke. The study used specialized software to visualize and quantify blood flow, identifying a quarter of patients with low posterior blood flow.
Researchers at USF are developing a new treatment for age-related hearing loss (ARHL), a neurodegenerative condition affecting 10% of the population. The Phase II clinical trial aims to investigate the therapeutic potential of modulating potassium channels in the brain.
The NELSON trial found that individuals with better health profiles and younger age were less likely to participate, but the study's findings remain relevant due to modest differences. The trial showed a higher mortality rate among eligible non-participants compared to participants.
A five-year follow-up study of patients with extreme obesity found that duodenal switch was more effective in reducing body weight than gastric bypass, but it came with a higher risk of complications. The study suggests that duodenal switch should be used with caution due to its adverse effects.
A recent study found that smartphone applications and wearable devices are generally accurate in tracking step counts, with minimal variation between devices. However, some wearables reported higher or lower counts than observed, highlighting the need for device accuracy assessment.
A new study published in JAMA found that smartphone apps are as accurate as wearable devices in tracking physical activity. The research used 10 top-selling smartphone apps and devices to compare their accuracy, with results showing smartphones were only slightly off from the observed step counts.
A study found that only 4% of published clinical trials mentioned FDA inspection violations, despite 74% having protocol violations. The FDA's lack of transparency and notification to journals contributes to this issue, making it difficult to track research misconduct.
A primary care-based program has been shown to increase physical activity in overweight, middle-aged women, with improvements of up to 90 minutes per week compared to self-guided groups. The interventionist-led group also maintained higher levels of activity over time.
A randomized trial assessing resident duty hour schedules in the ICU found that shorter hours may be less safe for patients and not associated with reduced fatigue. Longer shifts were linked to more severe symptoms of fatigue among residents. The study suggests trade-offs between residents' well-being and patient safety.
Research concludes that historical dietary guidelines on fat consumption in the US and UK were not supported by solid trial evidence. The analysis of six relevant trials found no difference in deaths from coronary heart disease between treatment and comparison groups.
Researchers developed a video game to measure upper extremity movement in patients with muscular dystrophy, highly correlating scores with daily activities and mobility. The game, using Kinect technology, measures patient performance and can be used across sites internationally.
A joint QUT, Cancer Council Queensland, and University of Queensland study tested the impact of SMS-delivered messages on skin cancer prevention and promotion. The Healthy Text trial found that texting improved self-reported sun protection habits and increased skin self-examination among participants.
A new clinical trial is exploring the use of breast MRI and genomic testing to guide treatment decisions for women with ductal carcinoma in situ (DCIS) breast cancer. The study aims to determine whether MRI findings can reduce the number of unnecessary mastectomies, a common concern among patients with DCIS.
A new course of action prescribing chemotherapy based on genetic research has led to a Phoenix resident being diagnosed with no detectable tumors after Stage 4 pancreatic cancer treatment. The patient benefited from a cutting-edge clinical trial and is now part of a follow-up study testing the effectiveness of a maintenance therapy.
The Liberia-NIH partnership is conducting a Phase 2/3 study to test the safety and efficacy of two experimental vaccines against Ebola virus infection. The trial will enroll approximately 27,000 healthy adults and those at high risk of infection, and will provide crucial information on potential countermeasures for future outbreaks.
A large randomized trial in the US found that adding STAN to conventional intrapartum fetal heart rate monitoring did not improve perinatal outcomes or decrease operative deliveries. The study's results highlight the need for caution when extrapolating results from studies outside the US.
The DFG is funding four new clinical trials addressing urgent questions in patient-oriented research, including surgery for metastatic stomach cancer and individualised chemotherapy for certain breast cancers. Over 1,160 patients will participate in the trials, which will test efficacy of new procedures over a three-year period.
A smartphone app improved some sun protection behaviors, including increased shade use and combined use of all sun protection behaviors. However, there was no significant difference in sunburns between groups. Strategies to increase mobile app usage are needed for effective deployment.
The GSK/NIH Ebola vaccine candidate has shown a well-tolerated safety profile and generated an immune response in healthy volunteers. Larger trials are necessary to assess whether the immune responses offer protection against Ebola infection and disease.
A clinical trial at Temple University Hospital is investigating the effectiveness of a vibrating capsule in alleviating symptoms of chronic constipation. The non-drug therapy involves a tiny motorized capsule that vibrates to stimulate intestinal contractions and help move stool through the digestive tract efficiently.
The University of Louisville is conducting a study to evaluate the safety and effectiveness of an investigational device called Zephyr Endobronchial Valve (EBV) for treating emphysema symptoms. The EBV blocks off diseased lung sections, allowing healthier parts to expand.
The Alzheimer's Association has awarded nearly $4 million in new grants to support five Phase 1 and 2a clinical trials exploring innovative treatments for Alzheimer's disease. These grants will help bridge the gap in funding for early-phase clinical drug trials, supporting promising projects from academia and industry.
Researchers developed a breast cancer risk prediction model specifically for African-American women, using data from 55,000 women. The new model predicts higher risk and is expected to increase the number of African-American women invited to participate in prevention trials.
The American College of Physicians marks its centennial year with a focus on the role of internal medicine in healthcare systems, professional satisfaction, and cost control. The journal also explores the challenges of sharing clinical trial data, highlighting the need for a consistent approach to balance benefits and risks.
The SPECTAcolor platform has successfully implemented across 19 European clinical centers, recruiting over 500 patients and providing high-quality biological materials. Preliminary analysis reveals mutations in key cancer biomarkers, including KRAS, NRAS, BRAF, PI3K, and mismatch repair.
The National Institute of Allergy and Infectious Diseases has awarded contracts to three organizations to conduct early-stage human clinical trials for investigational infectious disease treatments. The trials will test the safety of novel drugs against a range of emerging and re-emerging pathogens, including viruses and bacteria.
A new study found that reducing fear avoidance beliefs is crucial for improving symptoms and reducing disability in people with chronic fatigue syndrome. The analysis of PACE trial data revealed that graded exercise therapy (GET) was more effective than cognitive behavior therapy (CBT) in reducing fear avoidance beliefs.
Researchers from Inserm confirm triheptanoin's efficacy in treating Huntington's disease by restoring normal brain energy metabolism. A pilot clinical trial with ten patients showed significant improvements, paving the way for a larger-scale trial.
A prospective randomized controlled trial found that laparoscopic shunt placement reduced distal shunt failures, a common complication of ventriculoperitoneal shunt surgery. The study also showed comparable overall shunt malfunction rates and hospitalization times between the two groups.
A Phase 1B clinical trial in Uganda found the experimental vaccines safe and induced immune responses in healthy volunteers. The results are encouraging, as similar immune responses were observed compared to a previous US trial.
A study found that deeper or longer duration cooling did not improve outcomes for full-term infants with moderate or severe hypoxic ischemic encephalopathy. Longer cooling and deeper cooling has been shown to be neuroprotective in animal models, but its effectiveness was not observed in this trial.
A clinical trial has shown that a combination of well-known approved drugs is potentially safe for treating Charcot-Marie-Tooth type 1A disease, a rare genetic condition affecting 1 in 5,000. The drug combination, PXT3003, showed promising preliminary results for efficacy in improving symptoms and nerve function.